ES2082775T3 - Anticuerpos de proteinas latentes de papilomavirus humano, sistemas de diagnostico y procedimientos. - Google Patents
Anticuerpos de proteinas latentes de papilomavirus humano, sistemas de diagnostico y procedimientos.Info
- Publication number
- ES2082775T3 ES2082775T3 ES89304874T ES89304874T ES2082775T3 ES 2082775 T3 ES2082775 T3 ES 2082775T3 ES 89304874 T ES89304874 T ES 89304874T ES 89304874 T ES89304874 T ES 89304874T ES 2082775 T3 ES2082775 T3 ES 2082775T3
- Authority
- ES
- Spain
- Prior art keywords
- antibodies
- proteins
- procedures
- diagnostic systems
- latent human
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
- C07K16/084—Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
Abstract
LA INVENCION SE REFIERE A POLIPEPTIDOS QUE INMUNOLOGICAMENTE IMITAN A PROTEINAS LATENTES DEL VIRUS DE PAPILOMA Y A ANTICUERPOS Y ANTICUERPOS MONOCLONALES QUE INMUNORREACCIONAN CON LAS CITADAS PROTEINAS LATENTES. TAMBIEN SE REFIERE A SISTEMAS Y METODOS PARA DETECTAR LA PRESENCIA Y TIPO DE PAPILOMAVIRUS EN UN SUJETO HUMANO.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US19440788A | 1988-05-16 | 1988-05-16 | |
US07/323,614 US5180806A (en) | 1988-05-16 | 1989-03-13 | Polypeptides and compositions of human papillomavirus latent proteins, diagnostic systems and methods |
Publications (2)
Publication Number | Publication Date |
---|---|
ES2082775T3 true ES2082775T3 (es) | 1996-04-01 |
ES2082775T4 ES2082775T4 (es) | 1996-08-01 |
Family
ID=26889974
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES89304874T Expired - Lifetime ES2082775T4 (es) | 1988-05-16 | 1989-05-15 | Anticuerpos de proteinas latentes de papilomavirus humano, sistemas de diagnostico y procedimientos. |
Country Status (10)
Country | Link |
---|---|
US (3) | US5180806A (es) |
EP (1) | EP0344940B1 (es) |
JP (1) | JP2918904B2 (es) |
AT (1) | ATE130855T1 (es) |
CA (1) | CA1341287C (es) |
DE (1) | DE68924928T2 (es) |
DK (1) | DK173264B1 (es) |
ES (1) | ES2082775T4 (es) |
GR (1) | GR3018773T3 (es) |
PT (1) | PT90574B (es) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5932412A (en) * | 1990-05-11 | 1999-08-03 | Euro-Diagnostica Ab | Synthetic peptides in human papillomaviruses 1, 5, 6, 8, 11, 16, 18, 31, 33 and 56, useful in immunoassay for diagnostic purposes |
SE9001705D0 (sv) * | 1990-05-11 | 1990-05-11 | Medscand Ab | Saett foer diagnostik av virusbaerande tumoerer genom immunoassay |
EP0510912B1 (en) * | 1991-04-24 | 1998-01-07 | Morinaga Milk Industry Co., Ltd. | Antimicrobial peptide and antimicrobial agent |
PT523391E (pt) * | 1991-07-13 | 2003-08-29 | Dade Behring Marburg Gmbh | Utilizacao dos peptidos derivados dos genes hpv-16 e6 e e7 para fins de diagnostico |
DE4123760C2 (de) * | 1991-07-18 | 2000-01-20 | Dade Behring Marburg Gmbh | Seroreaktive Bereiche auf den HPV 16 Proteinen E1 und E2 |
US5437951A (en) * | 1992-09-03 | 1995-08-01 | The United States Of America As Represented By The Department Of Health And Human Services | Self-assembling recombinant papillomavirus capsid proteins |
GB9306731D0 (en) * | 1993-03-31 | 1993-05-26 | Cancer Res Campaign Tech | Vaccines |
DE19819476C1 (de) * | 1998-04-30 | 2000-01-05 | Deutsches Krebsforsch | Polypeptid mit immunogenen Eigenschaften und veränderten biologischen Funktionen eines Proteins |
GB2353581B (en) | 1999-08-27 | 2003-06-11 | Uponor Ltd | Swage lining |
US7026443B1 (en) | 1999-12-10 | 2006-04-11 | Epimmune Inc. | Inducing cellular immune responses to human Papillomavirus using peptide and nucleic acid compositions |
JP2001172200A (ja) * | 1999-12-17 | 2001-06-26 | Meneki Seibutsu Kenkyusho:Kk | ヒトナプシンaに対する抗体およびこれを用いる医薬 |
US6743593B2 (en) | 2000-04-05 | 2004-06-01 | Impact Diagnostics, Inc. | Immunological methodology for discerning human papillomavirus |
EP1288292A1 (en) * | 2001-08-31 | 2003-03-05 | Leids Universitair Medisch Centrum | Long peptides of 22-40 amino acid residues that induce and/or enhance antigen specific immune responses. |
US7202034B2 (en) | 2000-12-08 | 2007-04-10 | Academisch Ziekenhuis Leiden | Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses |
EP1352241A1 (en) * | 2000-12-21 | 2003-10-15 | Biosignature Diagnostics, Inc. | Absorbance multiplex technology |
US6933123B2 (en) | 2001-04-05 | 2005-08-23 | Yao Xiong Hu | Peptides from the E2, E6, and E7 proteins of human papilloma viruses 16 and 18 for detecting and/or diagnosing cervical and other human papillomavirus associated cancers |
GB2379220A (en) * | 2001-08-13 | 2003-03-05 | Univ York | Antibodies to HPV E2 protein |
WO2005025497A2 (en) * | 2003-09-05 | 2005-03-24 | Genencor International, Inc. | Hpv cd8+ t-cell epitopes |
CA2551560A1 (en) * | 2003-12-23 | 2005-07-14 | Arbor Vita Corporation | Antibodies for oncogenic strains of hpv and methods of their use |
CA2552508A1 (en) * | 2003-12-31 | 2005-09-29 | Pharmexa Inc. | Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositions |
US7732166B2 (en) * | 2005-11-15 | 2010-06-08 | Oncohealth Corporation | Detection method for human pappilomavirus (HPV) and its application in cervical cancer |
US7972776B2 (en) * | 2005-11-15 | 2011-07-05 | Oncohealth Corporation | Protein chips for HPV detection |
US8051950B2 (en) * | 2006-08-03 | 2011-11-08 | Glacier Bay, Inc. | System for reducing acoustic energy |
US20100003704A1 (en) * | 2008-06-13 | 2010-01-07 | Shuling Cheng | IN SITU detection of early stages and late stages HPV infection |
US8968995B2 (en) * | 2008-11-12 | 2015-03-03 | Oncohealth Corp. | Detection, screening, and diagnosis of HPV-associated cancers |
WO2009002159A2 (en) * | 2007-05-31 | 2008-12-31 | Academisch Ziekenhuis Leiden H.O.D.N. Lumc | Intradermal hpv peptide vaccination |
EP2427763A4 (en) | 2009-05-07 | 2013-08-21 | Oncohealth Corp | IDENTIFICATION OF HIGH GRADE OR CIN2 FOR DETECTION, MONITORING AND DIAGNOSIS, AT EARLY STAGES AND ADVANCED STAGES, OF HUMAN PAPILLOMAVIRUS (HPV) AND HPV ASSOCIATED CANCERS |
ES2641892T3 (es) * | 2009-08-26 | 2017-11-14 | Selecta Biosciences, Inc. | Composiciones que inducen la ayuda de las células T |
EP2521914A4 (en) | 2010-01-08 | 2013-07-10 | Oncohealth Corp | CELL-BASED HPV IMMUNOTESTS HAVE A HIGH PERFORMANCE FOR DIAGNOSIS AND SCANNING OF HPV ASSOCIATED CANCER |
US20110171248A1 (en) * | 2010-01-08 | 2011-07-14 | Selecta Biosciences, Inc. | Synthetic virus-like particles conjugated to human papillomavirus capsid peptides for use as vaccines |
CN103940993A (zh) * | 2013-01-23 | 2014-07-23 | 艾托金生物医药(苏州)有限公司 | 用于检测抗人乳头瘤病毒抗体的抗原及试剂盒和应用 |
EA202090149A1 (ru) * | 2017-06-28 | 2020-05-31 | Ридженерон Фармасьютикалз, Инк. | Антигенсвязывающие белки против вируса папилломы человека (hpv) и способы их применения |
US20210046114A1 (en) * | 2018-01-24 | 2021-02-18 | The Council Of The Queensland Institute Of Medical Research | Hpv immunotherapy |
CN113164445A (zh) | 2018-08-02 | 2021-07-23 | 得克萨斯系统大学评议会 | Tlr1/2激动剂地普罗考姆的佐剂作用协同增效检查点抑制性抗体以消除疾病 |
MX2022011765A (es) | 2020-03-26 | 2022-11-09 | Provectus Pharmatech Inc | Usos novedosos de xantenos halogenados en oncologia y virologia. |
US11938182B2 (en) | 2020-03-26 | 2024-03-26 | Provectus Pharmatech, Inc. | Halogenated xanthenes as vaccine adjuvants |
CN112920267B (zh) * | 2021-03-09 | 2021-08-13 | 北京康乐卫士生物技术股份有限公司 | 一种抗人乳头瘤病毒31型的单克隆中和抗体及其应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4748109A (en) * | 1983-07-01 | 1988-05-31 | Baird Phillip J | Assay method and reagent to determine antibodies to papillomavirus virions |
LU85462A1 (fr) * | 1984-07-11 | 1986-02-12 | Univ Louvain | Nouvelles compositions polymeres,procedes pour leur production et leurs applications |
US4777239A (en) * | 1986-07-10 | 1988-10-11 | The Board Of Trustees Of The Leland Stanford Junior University | Diagnostic peptides of human papilloma virus |
-
1989
- 1989-03-13 US US07/323,614 patent/US5180806A/en not_active Expired - Lifetime
- 1989-05-12 DK DK198902347A patent/DK173264B1/da not_active IP Right Cessation
- 1989-05-15 DE DE68924928T patent/DE68924928T2/de not_active Expired - Lifetime
- 1989-05-15 AT AT89304874T patent/ATE130855T1/de not_active IP Right Cessation
- 1989-05-15 CA CA000599671A patent/CA1341287C/en not_active Expired - Fee Related
- 1989-05-15 EP EP89304874A patent/EP0344940B1/en not_active Expired - Lifetime
- 1989-05-15 ES ES89304874T patent/ES2082775T4/es not_active Expired - Lifetime
- 1989-05-16 PT PT90574A patent/PT90574B/pt not_active IP Right Cessation
- 1989-05-16 JP JP1122691A patent/JP2918904B2/ja not_active Expired - Fee Related
-
1992
- 1992-12-23 US US07/996,027 patent/US5401627A/en not_active Expired - Lifetime
-
1993
- 1993-09-17 US US08/123,465 patent/US5486453A/en not_active Expired - Lifetime
-
1996
- 1996-01-24 GR GR960400172T patent/GR3018773T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
DK234789D0 (da) | 1989-05-12 |
US5180806A (en) | 1993-01-19 |
EP0344940B1 (en) | 1995-11-29 |
US5401627A (en) | 1995-03-28 |
ES2082775T4 (es) | 1996-08-01 |
JPH0296593A (ja) | 1990-04-09 |
PT90574A (pt) | 1989-11-30 |
US5486453A (en) | 1996-01-23 |
EP0344940A2 (en) | 1989-12-06 |
EP0344940A3 (en) | 1991-11-13 |
GR3018773T3 (en) | 1996-04-30 |
DK234789A (da) | 1989-11-17 |
DK173264B1 (da) | 2000-05-29 |
CA1341287C (en) | 2001-08-28 |
DE68924928D1 (de) | 1996-01-11 |
ATE130855T1 (de) | 1995-12-15 |
JP2918904B2 (ja) | 1999-07-12 |
DE68924928T2 (de) | 1996-10-17 |
PT90574B (pt) | 1994-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2082775T4 (es) | Anticuerpos de proteinas latentes de papilomavirus humano, sistemas de diagnostico y procedimientos. | |
DE59010787D1 (de) | Erythropoietin (EPO)-Peptide und dagegen gerichtete Antikörper | |
IT1083606B (it) | Contenitore particolarmente provetta per analisi o procedure immuno chomiche ed enzimatiche e procedimento per la sua fabbricazione | |
DE69228701T2 (de) | Fragmente von Prion Proteinen. | |
MY108526A (en) | Monoclonal antibodies against human interleukin-4 and hybridomas producing the same | |
ATE67313T1 (de) | Nachweis von menschlichem cytomegalovirusspezifischem igm. | |
DE3689948T2 (de) | Monoklonale antikörper und testverfahren. | |
DE3887053T4 (de) | Stlv-iii-verwandte polypeptide, diagnosesysteme und testmethoden. | |
GR3007000T3 (es) | ||
DE69028561D1 (de) | Immunoassay zum Nachweis von Antikörpern gegen HIV | |
ES2103017T3 (es) | Sueros estandares y de control para empleo en ensayos para anticuerpos. | |
DE3650635T2 (de) | Monoklonale Antikörper | |
DE3785175D1 (de) | A-assoziierte h-antigene, spezifische monoklonale antikoerper und methoden zu deren verwendung zur blutgruppenbestimmung. | |
ATE114818T1 (de) | Immuntest zum nachweis von alpha-haloacetamiden. | |
DE3886032T2 (de) | Hiv-1-verwandte polypeptide, diagnosesysteme und testverfahren. | |
NO900048D0 (no) | Paavisningsmetoder med individ-spesifikke antistoff. | |
ATE128717T1 (de) | Schizosaccharomyces-spezifische polypeptide. | |
DK305084D0 (da) | Partikel samt fremgangsmaade til paavisning af antigener og/eller antistoffer under anvendelse af partiklen |